Family Medicine · Jamaica, NY
NPI
1326721416
Since 2023
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10504 Sutphin Blvd
Jamaica, NY, 11435
Phone (855) 681-8700
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$141K
1,147 prescriptions
Company payments, 2025
$2,189
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Elaine de la Rosa Jerez prescribed most often to Medicare patients was Atorvastatin Calcium, with 81 prescriptions and refills. In total Elaine de la Rosa Jerez wrote 1,147 Medicare prescriptions that cost $141K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 81 | 99 | 25 | $302 |
| Lisinopril Generic | 53 | 71 | 13 | $153 |
| Metformin Hcl Generic | 52 | 71 | 14 | $161 |
| Pantoprazole Sodium Generic | 47 | 57 | Under 11 | $306 |
| Ozempic Semaglutide | 45 | 52 | 12 | $43K |
| Amlodipine Besylate Generic | 40 | 56 | 16 | $95.3 |
| Hydralazine Hcl Generic | 34 | 49 | Under 11 | $111 |
| Levothyroxine Sodium Generic | 29 | 37 | Under 11 | $255 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 | 27 | Under 11 | $621 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 26 | 27 | Under 11 | $56.81 |
| Diclofenac Sodium Generic | 25 | 29 | 12 | $340 |
| Metoprolol Succinate Generic | 24 | 33 | Under 11 | $121 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 24 | 28 | Under 11 | $532 |
| Fluticasone Propionate Generic | 23 | 28 | Under 11 | $175 |
| Metoprolol Tartrate Generic | 21 | 29 | Under 11 | $54.05 |
Brand drugs: 167 claims; generic drugs: 961 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elaine de la Rosa Jerez $2,189 ($2,189 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $813.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 19 | $813 |
| ViiV Healthcare Company GSK | 12 | $662 |
| Axsome Therapeutics, Inc. AXSM | 4 | $180 |
| EMD Serono, Inc. MRK.DE | 3 | $158 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $156 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $70.02 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.83 |
| Shield Therapeutics Inc STX.L | 2 | $40.54 |
| Scilex Pharmaceuticals Inc. | 1 | $22.92 |
| GlaxoSmithKline, LLC. GSK | 1 | $20.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.